Long-term use of combined conventional medicine and Chinese herbal medicine decreases the mortality risk of patients with lung cancer
- 19 May 2020
- journal article
- research article
- Published by Elsevier BV in Complementary Therapies in Medicine
- Vol. 52, 102427
- https://doi.org/10.1016/j.ctim.2020.102427
Abstract
No abstract availableKeywords
Funding Information
- Tzu Chi Foundation School and Hospital Cooperation Program
This publication has 44 references indexed in Scilit:
- Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers.) Fries: A reviewJournal of Ethnopharmacology, 2013
- The Efficacy of Chinese Herbal Medicine as an Adjunctive Therapy for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysisPLOS ONE, 2013
- Efficacy and safety of Suanzaoren decoction for primary insomnia: a systematic review of randomized controlled trialsBMC Complementary and Alternative Medicine, 2013
- Distributions of Usage and the Costs of Conventional Medicine and Traditional Chinese Medicine for Lung Cancer Patients in TaiwanEvidence-Based Complementary and Alternative Medicine, 2013
- Ontology-Oriented Diagnostic System for Traditional Chinese Medicine Based on Relation RefinementComputational and Mathematical Methods in Medicine, 2013
- Dyspnea Management in Early-Stage Lung CancerJournal of Hospice & Palliative Nursing, 2012
- Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodellingJournal of Pharmacy and Pharmacology, 2012
- Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAMCellular & Molecular Immunology, 2011
- Dyspnea in lung cancer patients: a systematic reviewLung Cancer: Targets and Therapy, 2010
- The mechanisms of action of Tianhua™on antitumor activity in lung cancer cellsPharmaceutical Biology, 2010